Physician profile
Jennifer E Bilker
NPI 1760236814
$2,262.53
in general payments reported to CMS, 2019-2025
22 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $813 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $543.23 | 2024-2025 | Wegovy, Ozempic |
| Kestra Medical Technology Services, INC. | $385.20 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $261.17 | 2024-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $162.29 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.65 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $99.58 | 2025 | Zepbound, Mounjaro |
| Irhythm Technologies, INC. | $91.46 | 2024 | Zio Monitor, Zio Xt Patch |
| Pfizer INC. | $75.85 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $73.05 | 2025 | Verquvo |
| Esperion Therapeutics, INC. | $59.81 | 2024-2025 | Nexletol |
| Amgen INC. | $59.67 | 2024-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $51.93 | 2024-2025 | Farxiga |
| Boston Scientific Corporation | $49.36 | 2024-2025 | Watchman Flx, Patientcare Link |
| Alnylam Pharmaceuticals INC. | $37.13 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $33.34 | 2024 | Arcalyst |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.21 | 2025 | Lifevest |
| Medtronic, INC. | $30.89 | 2025 | Linq II |
| Philips North America LLC | $24.03 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Bayer Healthcare Pharmaceuticals INC. | $20.13 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $19.70 | 2024 | |
| Medicomp INC | $17.82 | 2025 | Telepatch Cardiac Monitor |
| Vivaquant INC, Dba Rhythm Express | $11.03 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bilker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.